PATZ1 and diffuse large B-cell lymphoma: Moreover, as predicted by Kaplan Meier curves for evaluation of OS and PFS in DLBCL patients treated with R-CHOP, using different criteria, based either on RNA or protein expression, low levels of PATZ1 correlate with a worse outcome.